Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive

Steven Lebowitz1, Mariusz Kowalewski2,3,4, Giuseppe Maria Raffa5

  • 1University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Insights

Hypertrophic obstructive cardiomyopathy (HOCM) management requires careful patient selection for invasive treatments like surgical myectomy (SM) and alcohol septal ablation (ASA). This review compares standard and novel HOCM therapies, offering guidance for complex cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) presents heterogeneously with poor outcomes if untreated.
  • Standard invasive treatments include alcohol septal ablation (ASA) and surgical myectomy (SM).

Purpose of the Study:

  • To review standard invasive treatments (ASA, SM) for HOCM.
  • To summarize and compare novel HOCM management techniques.
  • To analyze current guidelines and suggest tailored treatments for complex HOCM presentations.

Main Methods:

  • Comprehensive literature search for evidence on ASA, SM, and other invasive HOCM treatments.
  • Inclusion of 103 significant publications after initial screening.

Main Results:

  • Analysis of guidelines and patient selection for standard and novel HOCM therapies.
  • Comparison of SM, ASA, dual-chamber pacing, and radiofrequency catheter ablation.
  • Consideration of complex pathoanatomic presentations and future therapies for HOCM.

Conclusions:

  • HOCM necessitates treatment to avoid poor long-term outcomes.
  • Effective HOCM treatment strategies exist, with patient selection being paramount.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...